DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements

NCT00550563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-04-04

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This clinical trial is studying changes in DNA that affect vitamin D metabolism in patients with colorectal cancer receiving vitamin D supplements.

Conditions

Interventions

DIETARY_SUPPLEMENT

cholecalciferol

Oral

GENETIC

polymerase chain reaction

companion study

GENETIC

polymorphism analysis

companion study

GENETIC

protein expression analysis

companion study

GENETIC

reverse transcriptase-polymerase chain reaction

companion study

GENETIC

western blotting

companion study

OTHER

high performance liquid chromatography

companion study

OTHER

laboratory biomarker analysis

companion study

OTHER

pharmacological study

companion study

PROCEDURE

adjuvant therapy

Additional therapy

PROCEDURE

immunoscintigraphy

additional testing

Sponsors & Collaborators

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Marwan Fakih, MD · Roswell Park Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-04-30
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550563 on ClinicalTrials.gov